USANA Health Sciences (USNA) CFO exercises RSUs, disposes shares for taxes

Filing Impact

(High)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

USANA Health Sciences' chief financial officer IIEKKING G DOUG reported equity award activity. On February 27, 2026, he exercised 7,469 Restricted Stock Units, converting them into the same number of common shares at $0.00 per share. Following this conversion, his directly held common stock position was 10,391 shares before a separate tax transaction. On the same date, 5,031 common shares were disposed of at $21.52 per share to cover tax obligations, leaving him with 5,360 common shares held directly. Footnotes state each restricted stock unit represents one share of common stock and that these units vest 25% on the anniversary of February 27, 2025.

Insider Trade Summary

7,469 shares exercised/converted

Mixed 3 txns

Insider IIEKKING G DOUG

Role CHIEF FINANCIAL OFFICER

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	7,469	$0.00	--
Exercise	Common Stock	7,469	$0.00	--
Tax Withholding	Common Stock	5,031	$21.52	$108K

Holdings After Transaction: Restricted Stock Units — 75,749 shares (Direct); Common Stock — 10,391 shares (Direct)

Footnotes (1)

Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Restricted Stock Units vest 25% on the anniversary of February 27th, 2025.

Form 4 Insider Transactions: What Each Field Means →

03/03/2026 - 12:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

IIEKKING G DOUG

(Last)

(First)

(Middle)

3838 WEST PARKWAY BLVD

(Street)

SALT LAKE CITY

84120

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/27/2026		M		7,469	A	⁽¹⁾	10,391	D
Common Stock	02/27/2026		F		5,031	D	$21.52	5,360	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	02/27/2026		M			7,469	⁽²⁾	⁽²⁾	Common Stock	7,469	$0	75,749	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. Restricted Stock Units vest 25% on the anniversary of February 27th, 2025.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did USANA Health Sciences (USNA) report for IIEKKING G DOUG?

USANA’s chief financial officer IIEKKING G DOUG exercised 7,469 Restricted Stock Units into common shares and disposed of 5,031 common shares to satisfy tax obligations, all dated February 27, 2026, leaving 5,360 common shares held directly afterward.

How many USANA (USNA) Restricted Stock Units did the CFO convert to common stock?

The CFO converted 7,469 Restricted Stock Units into 7,469 common shares at $0.00 per share. Each restricted stock unit represents a contingent right to receive one share of USANA common stock, according to the filing’s footnote explanation.

Why did USANA (USNA) CFO dispose of 5,031 common shares on February 27, 2026?

The 5,031 common shares were disposed of to pay the exercise price or tax liability, as indicated by transaction code F. This represents a tax-withholding disposition, not an open-market sale, at a reported price of $21.52 per share.

What is the CFO’s USANA (USNA) common stock holding after these Form 4 transactions?

After exercising Restricted Stock Units and the related tax-withholding disposition, the chief financial officer directly holds 5,360 shares of USANA common stock. This total is reported as the number of shares beneficially owned following the tax-related transaction.

How do USANA (USNA) Restricted Stock Units for the CFO vest?

The filing notes that the Restricted Stock Units vest 25% on the anniversary of February 27, 2025. Each unit represents a contingent right to receive one share of USANA common stock once the vesting and other applicable conditions are satisfied.

Did the USANA (USNA) CFO’s Form 4 show open-market buying or selling of shares?

The transactions involve exercising derivative securities and a tax-withholding disposition, not open-market trades. Shares were acquired through exercising 7,469 Restricted Stock Units and 5,031 shares were disposed of to cover tax obligations at $21.52 per share.